A phase I/II study of azacitidine in combination with temozolomide in patients with unresectable or metastatic soft tissue sarcoma or malignant mesothelioma.
Gleneara Elizabeth Bates
No relevant relationships to disclose
Robert N. Taub
No relevant relationships to disclose
Igor Matushansky
No relevant relationships to disclose
Thomas S. Uldrick
No relevant relationships to disclose
Maya Khandker
No relevant relationships to disclose
Yaakov Bressler
No relevant relationships to disclose
Yi Wang
No relevant relationships to disclose